← FDA DRUG APPROVALS

FDA ANDA · ANDA074045

NIFEDIPINE

Sponsor: VELZEN PHARMA PVT

APPLICATION
ANDA074045
TYPE
ANDA
ORIGINAL APPROVAL
1992-04-30
LATEST ACTION
2018-05-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

NIFEDIPINEPrescription
NIFEDIPINE 20MG · CAPSULE · ORAL

Approval history

2018-05-21Labeling · Supplement 8 · standardAP
2015-10-02Manufacturing (CMC) · Supplement 6 · unknownAP
2001-06-19Manufacturing (CMC) · Supplement 5AP
1998-12-31Manufacturing (CMC) · Supplement 4AP
1997-01-28Labeling · Supplement 3AP
1996-07-26Labeling · Supplement 2AP
1992-04-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →